Natriumoxybaat Aristo (Sodium Oxybate)

Sodium Oxybate, the active ingredient in Natriumoxybaat Aristo, is a GABA_B receptor agonist presented as an oral formulation for oral use. It is indicated for the treatment of narcolepsy with cataplexy and is sometimes used off‑label for alcohol dependence.

GNH USA supplies Natriumoxybaat Aristo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to strict quality standards and provides regulatory documentation for global distribution.

Sodium Oxybate is used in disorders of excessive daytime sleepiness and cataplexy, primarily within the narcolepsy therapeutic area. - Narcolepsy with cataplexy: reduces the frequency of cataplexy attacks and improves daytime alertness. - Excessive daytime sleepiness (narcolepsy): enhances wakefulness and reduces sudden sleep episodes. - Alcohol dependence (off‑label): may decrease cravings and withdrawal severity in some patients.

Sodium Oxybate may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Vomiting: occasional emesis.

Serious or Rare Side Effects: - Respiratory depression: reduced breathing rate that may require medical attention. - Seizures: rare occurrence of convulsive episodes. - Severe hypotension: sudden drop in blood pressure causing faintness.

When prescribing Sodium Oxybate, clinicians should observe several precautionary measures to ensure patient safety. - Pregnancy: risk unknown; avoid unless benefits outweigh potential hazards. - Breastfeeding: insufficient data; consider discontinuation during lactation. - Renal impairment: dose adjustment may be required; monitor renal function. - Concomitant CNS depressants: avoid or use with caution due to additive sedation. - Driving and operating machinery: patients may experience impaired alertness; advise caution. - Store at ambient temperature below 25°C: keep in original container, protect from moisture and light.

Sodium Oxybate can interact with other medicines, influencing its safety and efficacy.

Major Interactions (Avoid): - Alcohol: additive central nervous system depression may lead to severe respiratory depression. - Opioids or benzodiazepines: combined depressant effect increases risk of profound sedation. - Respiratory depressants (e.g., barbiturates): may cause life‑threatening breathing suppression.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): may alter sleep patterns; monitor for increased sedation. - Antihypertensive agents: possible additive hypotensive effect; check blood pressure. - Antiepileptic drugs: potential for altered seizure threshold; observe clinical response.